Library Subscription: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Published 6 issues per year

ISSN Print: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Liposomes a Vesicular Nanocarrier: Potential Advancements in Cancer Chemotherapy

Volume 29, Issue 5, 2012, pp. 355-419
DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i5.10
Get accessGet access

ABSTRACT

The indispensable obligation behind the successful therapy of a disease is to deliver the effective drug/bioactive concentration with sustained release manner at the diseased organs without any exposure to the healthy tissues. Novel drug-delivery systems increase the concentration and persistence of drug at the vicinity of the target site and thereby minimize the undesired side effects of the drug to the normal tissues of body. With advances in nanotechnology, several new drug delivery approaches have become available that may fulfil the requirement of safe and effective drug therapy. Among these techniques, vesicular drug-delivery systems, particularly liposomes, are under rigorous research for their applicability to deliver FDA-approved and newer drugs. Liposomes have been widely investigated as one of the most widely used nanocarriers in cancer therapy and have shown their potential in spatial and temporal release of bioactive agents for the effective treatment of various life-threatening diseases, including cancer. Various targeted and triggered-release approaches of bioactive substances using liposomes further improve the applicability of liposomes in cancer therapeutics. Thus, keeping these points in view, the present review has been focussed on application of liposomes for development of liposome technology and its novel applications for effective cancer therapy.

CITED BY
  1. Yang Yamin, Wang Hongjun, Perspectives of Nanotechnology in Minimally Invasive Therapy of Breast Cancer, Journal of Healthcare Engineering, 4, 1, 2013. Crossref

  2. Ferrari Raffaele, Colombo Claudio, Casali Cristina, Lupi Monica, Ubezio Paolo, Falcetta Francesca, D’Incalci Maurizio, Morbidelli Massimo, Moscatelli Davide, Synthesis of surfactant free PCL–PEG brushed nanoparticles with tunable degradation kinetics, International Journal of Pharmaceutics, 453, 2, 2013. Crossref

  3. Coulter J.A., Hyland W.B., Nicol J., Currell F.J., Radiosensitising Nanoparticles as Novel Cancer Therapeutics — Pipe Dream or Realistic Prospect?, Clinical Oncology, 25, 10, 2013. Crossref

  4. Semakov A. V., Blinkov A. A., Gaenko G. P., Vostrova A. G., Molotkovsky J. G., Synthesis and properties of lipophilic derivatives of 5-fluorouracil, Russian Journal of Bioorganic Chemistry, 39, 3, 2013. Crossref

  5. Biswas Amit Kumer, Islam Md Reazul, Choudhury Zahid Sadek, Mostafa Asif, Kadir Mohammad Fahim, Nanotechnology based approaches in cancer therapeutics, Advances in Natural Sciences: Nanoscience and Nanotechnology, 5, 4, 2014. Crossref

  6. Chan Kannie W.Y., Yu Tao, Qiao Yuan, Liu Qiang, Yang Ming, Patel Himatkumar, Liu Guanshu, Kinzler Kenneth W., Vogelstein Bert, Bulte Jeff W.M., van Zijl Peter C.M., Hanes Justin, Zhou Shibin, McMahon Michael T., A diaCEST MRI approach for monitoring liposomal accumulation in tumors, Journal of Controlled Release, 180, 2014. Crossref

  7. Shahin Mostafa, Safaei-Nikouei Nazila, Lavasanifar Afsaneh, Polymeric micelles for pH-responsive delivery of cisplatin, Journal of Drug Targeting, 22, 7, 2014. Crossref

  8. Serpooshan Vahid, Sivanesan Senthilkumar, Huang Xiaoran, Mahmoudi Morteza, Malkovskiy Andrey V., Zhao Mingming, Inayathullah Mohammed, Wagh Dhananjay, Zhang Xuexiang J., Metzler Scott, Bernstein Daniel, Wu Joseph C., Ruiz-Lozano Pilar, Rajadas Jayakumar, [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction, Biomaterials, 37, 2015. Crossref

  9. Moustafa Amira, Abd Rabo Moustafa Mahmoud M., Zilinskas Gregory J., Gillies Elizabeth R., Covalent drug immobilization in poly(ester amide) nanoparticles for controlled release, The Canadian Journal of Chemical Engineering, 93, 12, 2015. Crossref

  10. Janjic Jelena M., Bai Mingfeng, Design and Development of Theranostic Nanomedicines, in Nanotechnology for Biomedical Imaging and Diagnostics, 2015. Crossref

  11. Toro-Córdova Alfonso, Ledezma-Gallegos Fabricio, Mondragon-Fuentes Laura, Jurado Rafael, Medina Luis A., Pérez-Rojas Jazmin M., Garcia-Lopez Patricia, Determination of Liposomal Cisplatin by High-Performance Liquid Chromatography and Its Application in Pharmacokinetic Studies, Journal of Chromatographic Science, 54, 6, 2016. Crossref

  12. Buckway Brandon, Ghandehari Hamidreza, Nanotheranostics and In-Vivo Imaging, in Nanomedicine, 2016. Crossref

  13. Wang Yin, Liu Yan, Bailey Christopher, Zhang Huixia, He Miao, Sun Duxin, Zhang Peng, Parkin Brian, Baer Maria R., Zheng Pan, Malek Sami N., Liu Yang, Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin, Oncogene, 39, 14, 2020. Crossref

  14. Deng Zhou J., Morton Stephen W., Ben-Akiva Elana, Dreaden Erik C., Shopsowitz Kevin E., Hammond Paula T., Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment, ACS Nano, 7, 11, 2013. Crossref

  15. Gentile Emanuela, Cilurzo Felisa, Di Marzio Luisa, Carafa Maria, Anna Ventura Cinzia, Wolfram Joy, Paolino Donatella, Celia Christian, Liposomal chemotherapeutics, Future Oncology, 9, 12, 2013. Crossref

  16. Maktabi Sepehr, Malmstadt Noah, Schertzer Jeffrey W., Chiarot Paul R., An integrated microfluidic platform to fabricate single-micrometer asymmetric giant unilamellar vesicles (GUVs) using dielectrophoretic separation of microemulsions, Biomicrofluidics, 15, 2, 2021. Crossref

  17. Tampucci Silvia, Paganini Valentina, Burgalassi Susi, Chetoni Patrizia, Monti Daniela, Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle, Pharmaceutics, 14, 2, 2022. Crossref

  18. Tiwari Ankita, Gulbake Anamika Sahu, Kumar Pramod, Lipid nanoparticles and nanoemulsions exploited in the diagnosis and treatment of infectious diseases, in Nanotheranostics for Treatment and Diagnosis of Infectious Diseases, 2022. Crossref

  19. Xu Shengnan, Cui Cheng, Sun Manchao, Guo Sihui, Xu Ke, Cui Yanan, Gao Ziyin, Wu Zhenqi, Xue Jiaxin, Ma Yucai, He Xue, Cai Guofeng, Nano-Liposomal Encapsulation-Delivered Apelin-13 Attenuates Ev71 Infection-Induced Neurodegeneration by Modulating Il-6 and Tlr7, Journal of Modern Nanotechnology, 2, 1, 2022. Crossref

  20. Ali Asad , Akhtar Juber , Ahmad Usama, Basheer Abdul Samad , Jaiswal Neha , Jahan Afroz , Armamentarium in Drug Delivery for Colorectal Cancer , Critical Reviews™ in Therapeutic Drug Carrier Systems, 40, 1, 2023. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain